Inflation-adjusted Medicare reimbursement for primary and revision shoulder arthroplasty: an updated analysis
Journal of Shoulder and Elbow Surgery · 2026
DOI: 10.1016/j.jse.2025.08.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Shoulder and Elbow Surgery, 2026. Verfasst von Tej Joshi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Rutgers Health New Jersey Medical School, Newark, NJ, USA. Electronic address: tejpjoshi@gmail.com. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Shoulder, Medicare, Insurance, Health, Reimbursement, Inflation, Economic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Physician reimbursement for orthopedic procedures, such as total shoulder arthroplasty (TSA) and related revision surgeries, has been subject to economic pressures over the past 2 decades. Understanding trends in reimbursement, especially when adjusted for inflation, provides insight into health care economics and informs policy decisions. METHODS: The Physician Fee Schedule Look-Up Tool from the Centers for Medicare & Medicaid Services was queried to extract reimbursement data from 2000 to 2025 for various TSA procedures, including primary and revision surgeries. Current Procedural Terminology (CPT) codes 23470; 23472; 23473; 23474; 23334; and 23335 were included. All monetary values were converted to 2025 United States dollars using the Consumer Price Index to adjust for inflation. For each procedure, we calculated the mean annual reimbursement and trends in inflation-adjusted reimbursement through 2025. RESULTS: Across all procedures, there was a consistent decline in inflation-adjusted reimbursement. For instance, CPT code 23470 (hemiarthroplasty) decreased from $2,419.81 in 2000 to $1,192.43 in 2025. CPT code 23472 (TSA) showed a similar trend, declining from $2,467.96 in 2000 to $1,433.64 in 2025. Revision procedures, such as CPT code 23474 (humeral and glenoid component), experienced notable reductions, with a peak of $2,515.25 in 2015 falling to $1,718.62 in 2025. All linear regression models showed statistically significant downward trends (P < .001), with R2 values ranging from 0.885 to 0.915. CONCLUSION: Inflation-adjusted physician reimbursement for TSA procedures has declined substantially from 2000 to 2025. These findings highlight a continued decline in reimbursement despite stable or increasing procedural complexity, which may impact provider sustainability and access to care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, Rutgers Health New Jersey Medical School, Newark, NJ, USA. Electronic address: tejpjoshi@gmail.com.
- Department of Orthopaedics, Rutgers Health New Jersey Medical School, Newark, NJ, USA.
- Department of Orthopaedic Surgery, Hackensack University Medical Center, Hackensack, NJ, USA.
Zitieren
APA
Joshi, T., Katakam, A., Azer, A., Hawryluk, C., Bloh, A., Calem, D., Clements, A. J., Kohan, E. M., & Alberta, F. G. (2026). Inflation-adjusted Medicare reimbursement for primary and revision shoulder arthroplasty: an updated analysis. Journal of Shoulder and Elbow Surgery. https://doi.org/10.1016/j.jse.2025.08.028
Vancouver
Joshi T, Katakam A, Azer A, Hawryluk C, Bloh A, Calem D, et al. Inflation-adjusted Medicare reimbursement for primary and revision shoulder arthroplasty: an updated analysis. Journal of Shoulder and Elbow Surgery. 2026. doi:10.1016/j.jse.2025.08.028
BibTeX
@article{Joshi2026,
author = {Joshi, Tej and Katakam, Akhil and Azer, Amanda and Hawryluk, Christopher and Bloh, Andrew and Calem, Daniel and Clements, Ari J and Kohan, Eitan M and Alberta, Francis G},
title = {Inflation-adjusted Medicare reimbursement for primary and revision shoulder arthroplasty: an updated analysis},
journal = {Journal of Shoulder and Elbow Surgery},
year = {2026},
doi = {10.1016/j.jse.2025.08.028}
}
EUVIMED